Basketball Hall of Famer Dwyane Wade revealed Thursday that nearly half of one of his kidneys was removed in late 2023 after ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...